Could This Biologic Drug Work in Patients Lacking Its Target?

(MedPage Today) -- NEW ORLEANS--Apparently it's not necessary to have the protein that a monoclonal antibody is designed to bind for it to achieve a clinical benefit, if a study of patients with chronic urticaria can be taken at face value...